C3.ai NYSE: AI reported first-quarter fiscal 2027 revenue of $52.4 million, above its prior guidance, as the enterprise AI software company said its restructuring efforts, federal-sector momentum and product focus helped improve operating efficiency.
Get a deeper insight into the potential performance of C3.ai (AI) for the quarter ended July 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
C3.ai, Inc. (AI) closed the most recent trading day at $10.11, moving 1.84% from the previous trading session.
Sellers are enjoying booming sales but fretting over whether irreplaceable books are being “sent to the guillotine” to train large language models.
C3.ai, Inc. (AI) reached $9.7 at the closing of the latest trading day, reflecting a -2.32% change compared to its last close.
C3.ai (NYSE:AI | AI Price Prediction) currently trades at $10.18, while Wedbush Securities analyst Dan Ives carries a Street-high price target of $15 on the enterprise AI software company, implying roughly 47% upside from here.
In the closing of the recent trading day, C3.ai, Inc. (AI) stood at $10.63, denoting a +2.21% move from the preceding trading day.
C3.ai, Inc. (AI) concluded the recent trading session at $9.91, signifying a -1.39% move from its prior day's close.
The latest trading day saw C3.ai, Inc. (AI) settling at $9.07, representing a +2.49% change from its previous close.
C3.ai (AI) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Nebius Group N.V. NBIS and C3.ai, Inc. AI are capitalizing on the rapid adoption of AI, but they are pursuing distinct growth strategies to capture the expanding market opportunity.
C3.ai is positioned as a distressed, event-driven turnaround with a base case fair value of $10, ~12% above current levels. Federal segment bookings are compounding rapidly, the partner pipeline is strong, and expenses have been restructured, providing a credible path to stabilization. The thesis hinges on gross margin recovery, sustained federal growth, and flat opex, with Q1 FY2027 as the critical catalyst for validation.